Circulating endothelial cells and their subpopulations: role as predictive biomarkers in antiangiogenic therapy for colorectal cancer.
Several anticancer therapies have been developed to block angiogenesis, a key mechanism in tumor growth and metastasis. The predominantly cytostatic action of these compounds makes an assessment of their clinical activities inadequate if based only on the reduction of the tumor dimensions, as this may not reflect their true biologic efficacy. Thus, it is crucial to identify biomarkers that permit the recognition of potentially responsive subjects and to spare toxicity in those who are unlikely to benefit from treatment. Circulating endothelial cells (CECs) have been recently indicated as potential surrogate biomarkers of angiogenesis in several types of cancer. The possibility of rapidly quantifying these cells represents a promising tool for monitoring the clinical outcome of tumors with the potential to assess response to various treatments. However, the identification and quantification of CECs is technically difficult and not well standardized. A variety of methods to detect CECs in patients with solid tumors have been used; these are based on different technical approaches, combinations of surface markers, sample handling, and staining protocols. With an expanding interest in the field of potential clinical applications for CECs in oncology, the development of standardized protocols for analysis is mandatory. The aim of this review was to critically summarize the available data concerning the clinical value of CECs and their subpopulations as biomarkers of antiangiogenic therapy in patients with metastatic colorectal cancer.
['Manzoni|Mariangela|M|', 'Comolli|Giuditta|G|', 'Torchio|Martina|M|', 'Mazzini|Giuliano|G|', 'Danova|Marco|M|']
D020533:Angiogenesis Inhibitors D000970:Antineoplastic Agents D014408:Biomarkers, Tumor D015179:Colorectal Neoplasms D042783:Endothelial Cells D006801:Humans D009362:Neoplasm Metastasis D009389:Neovascularization, Pathologic
Circulating endothelial cell Biomarkers Colorectal cancer Angiogenesis Flow cytometry